Journal of Clinical Medicine (Mar 2021)

Prospective Study on Incidence, Risk Factors and Outcome of Recurrent <em>Clostridioides difficile</em> Infections

  • Guido Granata,
  • Nicola Petrosillo,
  • Lucia Adamoli,
  • Michele Bartoletti,
  • Alessandro Bartoloni,
  • Gregorio Basile,
  • Matteo Bassetti,
  • Paolo Bonfanti,
  • Raffaella Borromeo,
  • Giancarlo Ceccarelli,
  • Anna Maria De Luca,
  • Stefano Di Bella,
  • Sara Fossati,
  • Erica Franceschini,
  • Ivan Gentile,
  • Daniele Roberto Giacobbe,
  • Enrica Giacometti,
  • Fabrizio Ingrassia,
  • Filippo Lagi,
  • Giambattista Lobreglio,
  • Andrea Lombardi,
  • Laura Isabella Lupo,
  • Roberto Luzzati,
  • Alberto Enrico Maraolo,
  • Malgorzata Mikulska,
  • Mario Umberto Mondelli,
  • Alessandra Mularoni,
  • Cristina Mussini,
  • Alessandra Oliva,
  • Alessandro Pandolfo,
  • Carlotta Rogati,
  • Filippo Fabio Trapani,
  • Mario Venditti,
  • Pierluigi Viale,
  • Emanuela Caraffa,
  • Maria Adriana Cataldo,
  • on behalf of the ReCloDi (Recurrence of Clostridioides difficile Infection) Study Group

DOI
https://doi.org/10.3390/jcm10051127
Journal volume & issue
Vol. 10, no. 5
p. 1127

Abstract

Read online

Background: Limited and wide-ranging data are available on the recurrent Clostridioides difficile infection (rCDI) incidence rate. Methods: We performed a cohort study with the aim to assess the incidence of and risk factors for rCDI. Adult patients with a first CDI, hospitalized in 15 Italian hospitals, were prospectively included and followed-up for 30 d after the end of antimicrobial treatment for their first CDI. A case–control study was performed to identify risk factors associated with 30-day onset rCDI. Results: Three hundred nine patients with a first CDI were included in the study; 32% of the CDI episodes (99/309) were severe/complicated; complete follow-up was available for 288 patients (19 died during the first CDI episode, and 2 were lost during follow-up). At the end of the study, the crude all-cause mortality rate was 10.7% (33 deaths/309 patients). Two hundred seventy-one patients completed the follow-up; rCDI occurred in 21% of patients (56/271) with an incidence rate of 72/10,000 patient-days. Logistic regression analysis identified exposure to cephalosporin as an independent risk factor associated with rCDI (RR: 1.7; 95% CI: 1.1–2.7, p = 0.03). Conclusion: Our study confirms the relevance of rCDI in terms of morbidity and mortality and provides a reliable estimation of its incidence.

Keywords